For over three and a half decades, Charles “Cliff” Layton has been an influential figure in the nutraceutical community, shaping the industry with his expertise as a consultant to business start-ups, management teams, and IPO’s. But now, in a remarkable and transformative journey, he sets his sights on an even more groundbreaking frontier – the realm of MSC Exosomes and the ultimate regenerative practices. Throughout his career, Mr. Layton’s profound understanding of the intricacies surrounding manufacturing and distribution in the nutraceutical space has set him apart, earning him a reputation for delivering exceptional results and pioneering game-changing solutions.

A defining moment in Mr. Layton’s career came in 1995 when he played an instrumental role in introducing the first “Super Juice” to the American market. This revolutionary product achieved unprecedented success, over $50 million per month across 78 countries within a mere four years. This milestone not only solidified his position as a visionary but also underscored his ability to execute disruptive concepts that resonate globally.

In 2001 Mr. Layton founded the nutraceutical company Natures Balance, he was one of the pioneering minds responsible for successfully launching nutraceutical solutions on a massive scale over the internet. By leveraging the power of e-commerce, Mr. Layton showcased his entrepreneurial acumen and embraced technological advancements to make wellness products accessible to people worldwide.

Now, as the founder of OmniGenix, Mr. Layton embarks on a truly transformative venture into the realm of MSC Exosome therapy. Fueled by his passion for natural medicine and driven by an unyielding commitment to improving lives, he has assembled an extraordinary team and an unparalleled network of highly skilled individuals. Together, they are poised to revolutionize the field of regenerative medicine and redefine the possibilities of human health.

Drawing on his decades of experience, Mr. Layton aims to synergize the potential of Exosome therapy and making it readily accessible with his deep expertise in the nutraceutical industry. Through groundbreaking research, ethical practices, and unwavering dedication to humanity’s well-being, Mr. Layton and his team are set to make a lasting impact on the lives of millions, one cell at a time.

John Altshuler has been a trailblazer in business development and operations, leaving an indelible mark on industries ranging from health and wellness innovations, nutraceutical formulation and manufacturing to financial services. Known for his visionary leadership and strategic acumen, Mr. Altshuler has consistently demonstrated an exceptional ability to identify emerging trends, build high-performing teams, and create scalable business models that deliver extraordinary results.

Throughout his career, Mr. Altshuler has excelled at empowering individuals and organizations to unlock their potential. His expertise in cultivating high level business relationships and consultative business modeling has not only driven record-breaking growth but also fostered a culture of collaboration and innovation. By focusing on personal development, strategic partnerships, and ethical business practices, he has inspired countless entrepreneurs to achieve success and make meaningful contributions to their communities.

Mr. Altshuler’s impact extends far beyond traditional business metrics. He has been a key driver behind initiatives that have reshaped industries, including the introduction of innovative wellness products that have reached millions of consumers. His leadership has always been guided by a deep commitment to improving lives—financially, physically, and emotionally.

Now, as a co-founder and managing partner of OmniGenix, Mr. Altshuler is embarking on his most ambitious mission yet: revolutionizing health and wellness across the country through MSC-derived exosome products. Recognizing the critical gaps in traditional therapies and FDA regulation, he envisions a future where individuals and clinicians can have access to cutting edge solutions that provide extraordinary benefits.

By combining his decades of operational expertise with his passion for wellness, Mr. Altshuler is developing innovative programs that bridge the divide between healthcare affordability and accessibility. These products are designed to empower individuals and organizations to take control of their financial health while focusing on what truly matters—well-being.

With a clear vision and an unwavering dedication to making a difference, Mr. Altshuler is leading a movement that aims to redefine the relationship between health, wellness, and financial security. His legacy is one of relentless innovation, purposeful action, and a steadfast belief that transformative change is possible when passion and expertise align. As he forges ahead with OmniGenix, John Altshuler is not only redefining the boundaries of what’s possible in the health and wellness space but also setting a new standard for impactful leadership in business. His journey is an inspiration to those who seek to create
meaningful change and leave a lasting legacy.

Kendall Wood — Chief Growth & Technology Officer, OmniGenix

Kendall Wood unites enterprise-grade software engineering with results-driven marketing to accelerate adoption of OmniGenix’s regenerative  therapy solutions. Across twenty years, he has built and launched advanced demand-generation systems—pioneering one of the first true ringless-voicemail platforms, DropVM, refining compliance-ready LinkedIn and data-scraping automations, and developing simulation software adopted by small businesses, community colleges, universities, and national corporations such as GEICO.

At OmniGenix, Kendall architects the digital infrastructure behind our nationwide growth. He leads cross-functional teams that craft data-rich provider journeys, automate education funnels, and integrate HIPAA-secure analytics so clinicians can track outcomes while marketing responsibly. He also directs the OmniGenix Partner Accelerator, equipping physicians and wellness centers with turnkey assets, ROI calculators, and precision geotargeting—expanding our reach without compromising regulatory integrity.

A relentless advocate for technology-driven healthcare equity, Kendall channels visionary planning into hands-on execution, ensuring every line of code and every campaign advance one mission: make cutting-edge cellular regeneration accessible, affordable, and trusted.

McClane Duncan, ND—Medical Director & Clinical Educator, OmniGenix

Dr. Duncan McClane has spent more than two decades proving that modern technology and ancestral wisdom can coexist inside the same prescription pad. Board-certified in Naturopathic Medicine after earning his doctorate from the renowned Bastyr University, Dr. McClane grounds every decision in Vitalism—the belief that the body holds an intrinsic blueprint for healing. His career has been dedicated to decoding that blueprint, first through time-tested botanicals and dietetics, and now through the frontier science of mesenchymal stem-cell–derived exosome therapy at OmniGenix.

Long before exosomes entered mainstream discourse, Dr. McClane was refining the art of regenerative injection medicine. Post-graduate intensives with the Klinghardt Academy immersed him in prolotherapy, neurotherapy, platelet-rich plasma (PRP), and ozone applications, while additional certifications in ultrasound-guided joint injections and bio-fillers honed his procedural precision. He would go on to become a sought-after instructor, teaching physicians three times a year how to wield needles not merely for symptom relief, but for profound tissue renewal. These hands-on courses—spanning musculoskeletal ultrasound, micro-needling, and aesthetic biologics—translated his core philosophy into reproducible protocols other clinicians could trust.

Dr. McClane’s scientific curiosity has never stayed within one lane. Training under ozone pioneer Dr. Frank Shallenberger, completing Advanced Integrative Oncology modules with AAMP, earning T3 thyroid certification through AARM, and studying anthroposophic mistletoe therapy have all deepened his appreciation for the biochemical conversations that govern immunity, metabolism, and cellular repair. Each experience reinforced a single truth: when the correct biological signal is delivered in the correct context, the body responds.

That conviction drew him to OmniGenix. As Chief Medical Officer, Dr. McClane now channels his cumulative expertise into designing exosome-based protocols that are both clinically effective and patient-empowering. He leads practitioner academies, demystifying nanovesicle pharmacodynamics so that complex molecular concepts become actionable bedside decisions. On any given day you will find him scrutinizing batch analytics with our GMP scientists, coaching a rural primary-care team through their first knee-joint exosome injection, or consulting on IRB-approved studies measuring inflammation biomarkers and functional outcomes.

Dr. McClane’s commitment to making complex medicine simple extends beyond the clinic walls. He spearheads OmniGenix’s educational platform, producing step-by-step video libraries, live webinars, and protocol playbooks that translate bench data into real-world healing. Patients appreciate his ability to reconnect them with their own physiology—explaining how exosomes act as bio-intelligent messengers rather than foreign drugs, orchestrating cascades of anti-inflammatory and regenerative signals already scripted into their DNA.

From his early days earning a B.S. in Biology at the University of Houston–Downtown to his current role shepherding OmniGenix therapies into mainstream practice, Dr. McClane has remained unwavering in purpose: reignite the body’s innate capacity for renewal and teach others to do the same. Under his guidance, OmniGenix is not merely distributing exosomes; we are cultivating a global community of clinicians armed with the knowledge, compassion, and evidence to rewrite the future of regenerative medicine—one precise cellular signal at a time.

McClane Duncan, ND

Approach

“My medical approach is rooted in Vitalism, a system of medicine that focuses on cure, using the body’s own innate ability to heal. I employ time-tested natural therapies, as well as the latest medical technology to develop sustainable health plans that empower my patients to take control of their health. My goals are to make complex medicine simple, reconnect people with their bodies, and teach my patients the foundations of health.”

Education

• Doctorate Degree: Doctor of Naturopathic Medicine, Bastyr University
• Post Graduate Training: PRP, Prolotherapy, Neurotherapy, and Ozone therapy, Klinghardt Academy, Anthroposophical Medical Training
• Undergraduate Degree: Bachelor of Science in Biology, University of Houston-Downtown

Advanced Training

• Neurotherapy: Klinghardt Institute 2014 https://klinghardtinstitute.com/
• Advanced Ozone and Prolozone certification with Dr. Frank Shallenberger
• PRP, PRF, & Bio Filler Certification AAEG 2018: https://aaeg.education/
• Micro Needling Certification AAEG 2018: https://aaeg.education/
• Musculoskeletal Ultrasound guided injection certification.  R3 medical training https://r3medicaltraining.com/courses/
• Aesthetic use of Botox and Fillers: AMET 2022 Aesthetic Medical Educators Training
• T3 Certification: AARM https://restorativemedicine.org/conferences/t3-certification/
• Fundamental Best Practices of Mistletoe Anthroposophic Medicine Community
• Advanced Applications in Integrative Oncology 2023: AAMP https://aampconferences.com/

Injection Therapy

Dr. McClane Duncan has been practicing Regenerative Injection Therapy for years, is very skilled at it and teaches it to other healthcare providers three times a year.

Greg McKettrick, RPh, is a nationally recognized compounding pharmacist and clinical educator with more than 35 years of experience spanning men’s health, hormone optimization, sexual wellness, and advanced therapeutic protocols. He serves as Chief Medical Advisor to OmniGenix, providing clinical oversight, practitioner education, and strategic guidance in regenerative medicine, peptides, and biologic therapies.

Greg has worked extensively with patients suffering from sexual dysfunction and hormone imbalance, with a particular clinical focus on post-prostatectomy recovery. His work in erectile dysfunction led to the development of the Post-Prostatectomy Penile Rehabilitation Protocol, a clinically adopted program now utilized by urology clinics across the United States. This protocol has been published in multiple professional articles, and its companion resource site, PenileRehabProtocol.com, serves men and families navigating prostate cancer recovery.

He currently serves on the Revelation Pharma team as a Men’s Health Clinical Liaison and Regional Director – Therapeutic Line Specialist, supporting urology, OB/GYN, and hormone-focused practices nationwide. In this role, Greg functions as a clinical resource for prescribers and patients, while also supporting pharmacists, sales teams, and operations staff to elevate education, outcomes, and sustainable practice growth.

Greg is a co-founder of Live Harder Health, a healthcare company delivering non-prescription and practitioner-supported solutions, including exosomes, physician-use peptides, medicinal mushrooms, supplements, dermal therapies, and clinical and business consulting services.

Beyond OmniGenix, Greg holds multiple national advisory and academic roles. He is a Senior Medical Advisor for the BHRT Training Academy, an Adjunct Faculty Member for Peptide University, a Scientific Advisory Board member for Berkeley Life Nitric Oxide, and a national speaker for ZERO Prostate Cancer (ZERO). He also serves as a guest lecturer in Integrated Pharmaceutical Sciences at High Point University School of Pharmacy, contributing to the education of future clinicians.

Greg hosts the weekly podcast Hard Facts on the RxConnexion platform, where he delivers evidence-based education and practical therapeutic insights focused on sexual dysfunction, hormone imbalance, and emerging treatment modalities.

At OmniGenix, Greg brings a rare combination of deep clinical experience, educator credibility, and practical implementation expertise, supporting the company’s mission to set the highest standards in regenerative medicine through validated science, responsible clinical application, and practitioner excellence.

Dr. Doug Yoch is a nationally respected pharmacy executive and formulation strategist with more than 30 years of experience across clinical pharmacy, sterile and non-sterile compounding, regulatory compliance, and pharmaceutical business leadership. He currently serves as Chief Medical Advisor for Pharmacy & Formulation Strategy at OmniGenix, where he provides senior-level guidance on product evaluation, formulation integrity, regulatory considerations, and practitioner education across OmniGenix’s regenerative and peptide platforms.

Dr. Yoch brings a rare combination of clinical depth, operational mastery, and regulatory fluency, making him a key strategic asset as OmniGenix continues to set the gold standard in regenerative medicine. His advisory role focuses on ensuring that OmniGenix products and protocols meet the highest benchmarks for safety, consistency, and scientific validity—bridging real-world clinical application with best-in-class pharmaceutical standards.

In parallel, Dr. Yoch serves as Director of Formulation Strategy and Shareholder at Revelation Pharma, one of the largest and most respected compounding pharmacy networks in the United States. In this role, he leads formulation development strategy, supports regulatory compliance initiatives, and collaborates across clinical, technical, and operational teams to advance personalized medicine at scale.

Dr. Yoch also holds leadership and advisory roles with Prollenium US (Head of Pharmacy) and Ananda Professional (Director of Pharmacy Services), where he consults executive teams on pharmacy operations, formulation strategy, and clinician-facing education, including emerging therapeutic categories.

Previously, Dr. Yoch was the owner and operator of Stanley Specialty Pharmacy in Charlotte, North Carolina, which he led for over two decades. Under his leadership, Stanley Specialty Pharmacy became one of the region’s most trusted compounding pharmacies, providing advanced sterile and non-sterile compounded medications for both human and veterinary patients while maintaining exceptional regulatory and quality standards.

Dr. Yoch has also served in national leadership roles within the profession, including as a Board Member and Membership Committee Chair for the Alliance for Pharmacy Compounding, and holds the distinction of Fellow of the Alliance for Pharmacy Compounding (FAPC)—recognizing his contributions to advancing the field of compounding pharmacy.

At OmniGenix, Dr. Yoch’s involvement reinforces the organization’s commitment to measurable science, disciplined formulation, and regulatory excellence, providing practitioners and partners with confidence that every product and protocol is guided by experienced clinical oversight and pharmaceutical rigor.